A 21st Century Response to the Cures Act
Patients’ unfettered access to complex test results can lead to confusion and distress—but generative AI can help.
Patients’ unfettered access to complex test results can lead to confusion and distress—but generative AI can help.
From - Diagnostic Testing & Emerging Technologies
iSpecimen (Lexington, Mass.) can be thought of as a cross between a dating site and an online marketplace for human biospecimens. The company has built…
From - Diagnostic Testing & Emerging Technologies
A constant refrain within the diagnostics industry is a need for standardization. Rapidly developing technology and testing methods, the call for interoperability, and the vast amount of …
From - Diagnostic Testing & Emerging Technologies
Personalized medicine is driving the need for isolation of rarer target cell populations, including for the enrichment of…
From - Diagnostic Testing & Emerging Technologies
Like all other industries, the laboratory industry will feel the effects of the digital revolution. In some cases, digital technology will make operations more efficient and cut human errors by…